Genotyping Support Services
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
NATIONAL INSTITUTES OF HEALTH NIDA
Contract Value
Not provided
Codes & Classification
Solicitation Number
75N95026R00006
NAICS
541690 - Other Scientific and Technical Consulting Services
Classification Code
R499
Additional Details
Documents5
The National Institutes of Health (NIH), specifically the National Institute on Drug Abuse (NIDA), has issued a combined synopsis/solicitation for commercial genotyping support services under solicitation number 75N95026R00006. This procurement, titled the "NIA Genotyping Outsourcing Project," seeks qualified vendors to provide DNA extraction and multi-gene analysis from rodent tissue samples. The objective is to outsource specialized genotyping services to support ongoing scientific research, ensuring high-quality, reliable genetic data from rodent specimens.
The scope of work encompasses the extraction of deoxyribonucleic acid (DNA) and subsequent multi-gene analysis, as detailed in the attached Statement of Work (SOW). Contractors are expected to demonstrate technical capability in handling rodent tissue samples, performing DNA extraction, and conducting comprehensive gene analyses. The anticipated outcome is the provision of accurate and timely genotyping data that will facilitate NIH research initiatives.
This acquisition is classified under NAICS code 541690 (Other Scientific and Technical Consulting Services), with a small business size standard of $16.5 million. There are no set-aside restrictions, making this opportunity open to all qualified vendors regardless of business size. The procurement will result in an Indefinite Delivery Indefinite Quantity (IDIQ) contract, with an ordering period projected from April 4, 2026, through April 3, 2031. This long-term contract structure is designed to accommodate fluctuating research needs over a five-year period.
The solicitation is conducted in accordance with Federal Acquisition Regulation (FAR) Part 12 for commercial items and exceeds the simplified acquisition threshold. Provisions and clauses incorporated by reference include FAR 52.204-7 (System for Award Management), FAR 52.212-1 (Instructions to Offerors—Commercial Items), HHSAR 352.239-73 (Electronic and Information Technology Accessibility Notice), and others relevant to commercial item acquisitions. Offerors must comply with these requirements and ensure active registration in the System for Award Management (SAM).
Evaluation criteria for award include technical capability, price, and past performance, with technical capability and past performance weighted significantly more than price. Offerors are required to submit evidence of their ability to fulfill the technical requirements, along with a detailed price proposal that includes labor categories, estimated hours, fully loaded hourly rates, and a breakdown of other direct costs or materials. Additionally, offerors must provide their Unique Entity Identifier (UEI) and certify their business size.
The contracting entity is the NIH NIDA, operating under the Department of Health and Human Services. The primary point of contact for this solicitation is Scott Duernberger, Contract Specialist ([email protected], 301-594-0670), with Kelly Dempsey serving as the Contracting Officer ([email protected]). All responses must be submitted electronically by 12:00 p.m. Eastern Time on Friday, March 20, 2026. Fax responses will not be accepted.
This opportunity is active and posted on SAM.gov, with additional details and attachments available at https://sam.gov/opp/08c38f3843f745c6806d73784742c5f8/view. Contractors interested in supporting NIH’s genotyping needs are encouraged to review the full solicitation and attachments to assess alignment with their capabilities and submit a comprehensive proposal by the specified deadline.
Key elements that will remain constant throughout the contract lifecycle include the requirement for DNA extraction and multi-gene analysis from rodent tissue samples, adherence to federal acquisition regulations, and the IDIQ contract structure supporting NIH’s ongoing research needs. The contract will be governed by the incorporated provisions and clauses, ensuring compliance and performance standards are maintained.
For further information or clarification regarding the solicitation, contractors should contact Scott Duernberger at the provided email or phone number.